Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Transforming pathways activated by the v-Abl tyrosine kinase

Oncogene volume 21, pages 8568–8576 (2002)Cite this article

Abstract

The Abelson Murine Leukemia Virus (A-MuLV) is the acute transforming retrovirus encoding the v-abl oncogene. Two isolates of the virus encoding proteins of p120 Kd and 160 Kd have been extensively studied. These viral isolates have been found to transform both hematopoietic and fibroblastic cells in vitro, while inducing predominantly pre-B cell leukemias in vivo. Both p120v-Abl and p160v-Abl are plasma membrane-associated non-receptor tyrosine kinases and the transforming activity of these proteins requires their tyrosine kinase activity. A-MuLV infection of hematopoietic cells has often been found to result in the abrogation of their cytokine-dependence for growth. In addition, v-Abl expressing hematopoietic cells often lose their ability to differentiate in response to appropriate cytokines. This review discusses some of the early transformation studies of A-MuLV, as well as some of the findings concerning the structure and biochemical activity of the v-Abl protein. Finally, we discuss the mechanisms associated with v-Abl mediated transformation through examination of the various signal transduction pathways activated by this oncogene.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Abelson HT, Rabstein LS . 1970a Cancer Res. 30: 2208–2212

  • Abelson HT, Rabstein LS . 1970b Cancer Res. 30: 2213–2222

  • Banerjee A, Rothman P . 1998 J. Immunol. 161: 4611–4617

  • Beg AA, Baltimore D . 1996 Science 274: 782–784

  • Ben-Neriah Y, Bernards A, Paskind M, Daley GQ, Baltimore D . 1986 Cell 44: 577–586

  • Burfoot MS, Rogers NC, Watling D, Smith JM, Pons S, Paonessaw G, Pellegrini S, White MF, Kerr IM . 1997 J. Biol. Chem. 272: 24183–24190

  • Chen CJ, Turner J, Watson AJM, Dive C . 1997 Oncogene 15: 2249–2254

  • Chen YY, Rosenberg N . 1992 Proc. Natl. Acad. Sci. USA 89: 6683–6687

  • Chen YY, Wang LC, Huang MS, Rosenberg N . 1994 Genes Dev. 8: 688–697

  • Cleveland J, Dean M, Rosenberg N, Wang J, Rapp U . 1989 Mol. Cell. Biol. 9: 5685–5695

  • Cook WD, Metcalf D, Nicola NA, Burgess AW, Walker F . 1985 Cell 41: 677–683

  • Cong F, Yuan B, Goff SP . 1999a Mol. Cell. Biol. 19: 8314–8325

  • Cong F, Zou X, Hinrichs K, Calame K, Goff SP . 1999b Oncogene 18: 7731–7739

  • Coutts M, Zou X, Calame K . 2000 Oncogene 19: 801–809

  • Danial NN, Losman JA, Lu T, Yip N, Krishnan K, Krowlewski J, Goff SP, Wang JYJ, Rothman PB . 1998 Mol. Cell. Biol. 18: 6795–6804

  • Danial NN, Pernis A, Rothman PB . 1995 Science 269: 1875–1877

  • Darnell Jr JE, Kerr IM, Stark GR . 1994 Science 264: 1415–1421

  • DiCristofano A, Niki M, Zhao M, Karnell FG, Clarkson B, Pear WS, Van Aelst L, Pandolfi PP . 2001 J. Exp. Med. 194: 275–284

  • Engleman A, Rosenberg N . 1990 Mol. Cell. Biol. 10: 4365–4369

  • Evans CA, Lord JM, Owen-Lynch PJ, Johnson G, Dive C, Whetton AD . 1995 J. Cell. Sci. 108: 2591–2598

  • Foo SY, Nolan GP . 1999 Trends Genet. 15: 229–235

  • Goff SP, Gilboa E, Witte ON, Baltimore D . 1980 Cell 22: 777–785

  • Green PL, Kaehler DA, Bennett LM, Risser R . 1989 J. Virol. 63: 1989–1994

  • Gutteridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS . 1999 Mol. Cell. Biol. 19: 5785–5799

  • Hinz MD, Krapmann D, Eichten A, Heder A, Scheiderit C, Stauss M . 1999 Mol. Cell. Biol. 19: 2690–2698

  • Hori Y, Kaibuchi K, Fukumoto Y, Oku N, Takai Y . 1990 Oncogene 5: 1201–1206

  • Huang TS, Kuo ML, Shew JY, Chou YW, Yang WK . 1996 Oncogene 13: 625–632

  • Hunter T . 1993 Nature 366: 114–116

  • Jahn T, Seipel P, Coutinho S, Miething C, Peschel C, Duyster J . 2001 J. Biol. Chem. 276: 43419–43427

  • Kauffman-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G . 1997 Nature 385: 544–548

  • Keller JR, Ruscetti SK, Ruscetti FW . 1990 Oncogene 5: 549–555

  • Kipreos E, Wang JYJ . 1992 Science 256: 382–385

  • Kipreos ET, Wang JY . 1988 Oncogene Res. 2: 277–284

  • Kishimoto T, Taga T, Akira S . 1994 Cell 76: 253–262

  • Klug CA, Gerety SG, Shah PC, Chen Y-Y, Rice NR, Rosenberg N, Singh H . 1994 Genes Dev. 8: 678–687

  • Latt SA, Goff SP, Tabin CJ, Paskind M, Wang JYJ, Baltimore D . 1983 J. Virol. 45: 1195–1199

  • Mathey-Prevot B, Baltimore D . 1998 Mol. Cell Biol. 8: 234–240

  • Mathey-Prevot B, Nabel G, Palacios R, Baltimore D . 1986 Mol. Cell. Biol. 6: 4133–4135

  • McGahon AJ, Nishioka WK, Martin SJ, Mahboubi A, Cotter TG, Green DG . 1995 J. Biol. Chem. 270: 22625–22631

  • Moloney JB . 1960 J. Nat. Cancer Inst. 24: 933–951

  • Nepveu A, Fahrlander PD, Yang J-Q, Marcu KB . 1985 Nature 317: 440–443

  • Oppi C, Shore SK, Reddy EP . 1987 Proc. Nat. Acad. Sci. USA 84: 8200–8204

  • Owen PJ, Musk P, Evans CA, Wetton AD . 1993 J. Biol. Chem. 268: 15696–15703

  • Parmar K, Rosenberg N . 1996 J. Virol. 70: 1009–1015

  • Premkumar E, Potter M, Singer PA, Sklar MD . 1975 Cell 6: 149–159

  • Prywes R, Foulkes JG, Baltimore D . 1985 J. Virol. 54: 114–122

  • Prywes R, Foulkes JG, Rosenberg N, Baltimore D . 1983 Cell 34: 569–579

  • Rabstein LS, Gazdar AF, Chopra HC, Abelson HT . 1971 J. Natl. Cancer Inst. 46: 481–491

  • Radfar A, Unnikrishnan I, Lee H-W, DePinho RA, Rosenberg N . 1998 Proc. Natl. Acad. Sci. USA 95: 13194–13199

  • Raffel GD, Parmar K, Rosenberg N . 1996 J. Biol. Chem. 271: 4640–4645

  • Raitano AB, Halpern JR, Hambuch TM, Sawyers CL . 1995 Proc. Natl. Acad. Sci. USA 92: 11746–11750

  • Raschke WC, Ralph P, Watson J, Sklar MD, Coon H . 1975 J. Natl. Cancer Inst. 54: 1249–1253

  • Raschke WC, Baird S, Ralph P, Nankoninz I . 1978 Cell 15: 261–267

  • Reddy EP, Dunn CY, Aaronson SA . 1980 Cell 19: 663–669

  • Reddy EP, Smith MJ, Srinivasan A . 1983 Proc. Nat. Acad. Sci. USA 80: 3623–3627

  • Ren R, Ye Z-S, Baltimore D . 1994 Genes Dev. 8: 783–795

  • Renshaw MW, Kipreos ET, Albrecht MR, Wang JYJ . 1992 EMBO J. 11: 3941–3951

  • Renshaw MW, Lea-Chou E, Wang JYJ . 1996 Curr. Biol. 6: 76–83

  • Rosenberg N, Baltimore D, Scher CD . 1975 Proc. Nat. Acad. Sci. USA 72: 1932–1936

  • Rosenberg N, Baltimore D . 1976 J. Exp. Med. 143: 1453–1463

  • Rosenberg N, Witte ON . 1980 J. Virol. 33: 340–348

  • Rosenberg N, Clark DR, Witte ON . 1980 J. Virol. 36: 766–774

  • Rosenberg N, Witte ON, Baltimore D . 1979 Cold Spring Harbor Symp. Quant. Biol. 44: 859–864

  • Rovera G, Valtieri M, Mavilio F, Reddy EP . 1987 Oncogene 1: 29–35

  • Ryan KM, Ernst MK, Rice NR, Vousden KH . 2000 Nature 404: 892–897

  • Saez E, Oppenheim H, Smoluk J, Anderson J, Van Etten RA, Spiegelman BM . 1995 Cancer Res. 55: 6196–6199

  • Sawyers C, Callahan W, Witte ON . 1992 Cell 70: 901–910

  • Sawyers CL, McLaughlin J, Witte ON . 1995 J. Exp. Med. 181: 307–313

  • Scher CD, Siegler R . 1975 Nature 253: 729–731

  • Schultz A, Oroszlan S . 1984 Virology 133: 431–437

  • Siegler R, Zajdel S, Lane I . 1972 J. Natl. Cancer Inst. 48: 189–218

  • Sklar MD, White BJ, Rowe WP . 1974 Proc. Nat. Acad. Sci. USA 71: 4077–4081

  • Songyang Z, Yamanashi Y, Liu D, Baltimore D . 2001 J. Biol. Chem. 276: 2459–2465

  • Srinivasan A, Dunn CY, Yuasa Y, Devare SG, Reddy EP, Aaronson SA . 1982 Proc. Nat. Acad. Sci. USA 79: 5508–5512

  • Srinivasan A, Reddy EP, Aaronson SA . 1981 Proc. Nat. Acad. Sci. USA 78: 2077–2081

  • Stacey D, Roudebush M, Day R, Moser S, Gibbs J, Fieg L . 1991 Oncogene 6: 2297–2304

  • Stahl N, Yancopoulos GD . 1993 Cell 74: 587–590

  • Taniguchi T . 1995 Science 268: 251–255

  • Tang X, Downes CP, Whetton AD, Owen-Lynch PJ . 2000 J. Biol. Chem. 275: 13142–13148

  • Tanka M, Gupta R, Mayer BJ . 1995 Mol. Cell. Biol. 15: 6829–6837

  • Thome KC, Adafar A, Rosenberg N . 1997 J. Virol. 71: 8149–8156

  • Unnikrishnan I, Radfar A, Jenab-Wolcott J, Rosenberg N . 1999 Mol. Cell. Biol. 19: 4825–4831

  • Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM . 1996 Science 274: 787–789

  • Varticovski M, Daley GQ, Jackson P, Baltimore D, Cantley LC . 1991 Mol. Cell. Biol. 11: 1107–1113

  • Waneck GL, Keyes L, Rosenberg N . 1986 Cell 44: 337–344

  • Wang JYJ . 1993 Curr. Opin. Genetics Dev. 3: 35–43

  • Wang C-Y, Mayo MW, Baldwin AS . 1996 Science 274: 784–787

  • Wang JYJ, Ledley F, Goff S, Lee R, Groner Y, Baltimore D . 1984 Cell 36: 349–356

  • Wong K-K, Zou X, Merrell KT, Patel AJ, Marcu KB, Chellappan S, Calame K . 1995 Mol. Cell. Biol. 15: 6535–6544

  • Whitlock CS, Zeigler SF, Witte ON . 1983 Mol. Cell. Biol. 3: 596–604

  • Winston LA, Hunter T . 1995 J. Biol. Chem. 270: 30837–30840

  • Witte ON, Dasgupta A, Baltimore D . 1980 Nature 283: 826–831

  • Witte ON, Sun L, Rosenberg N, Baltimore D . 1979 Cold Spring Harbor Symp. Quant. Biol. 44: 855–857

  • Yamanashi Y, Baltimore D . 1997 Cell 88: 205–211

  • Zhu J, Nabissa PM, Hoffman B, Liebermann DA, Shore SK . 1996 Blood 87: 4368–4375

  • Ziegler SF, Whitlock CA, Goff SP, Gifford A, Witte ON . 1981 Cell 27: 477–486

  • Zou X, Cong F, Coutts M, Cattoretti G, Goff SP, Calame K . 2000 Mol. Cell. Biol. 20: 628–633

  • Zou X, Rudchenko S, Wong K-K, Calame K . 1997 Genes Dev. 11: 654–662

Download references

Author information

Authors and Affiliations

  1. Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, 3307 N Broad Street, Philadelphia, 19140, Pennsylvania, PA, USA

    Scott K Shore, Ramana V Tantravahi & E Premkumar Reddy

Authors
  1. Scott K Shore
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ramana V Tantravahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E Premkumar Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E Premkumar Reddy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shore, S., Tantravahi, R. & Reddy, E. Transforming pathways activated by the v-Abl tyrosine kinase. Oncogene 21, 8568–8576 (2002). https://doi.org/10.1038/sj.onc.1206084

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206084

Keywords

This article is cited by

Search

Advanced search

Quick links